Senior Editor At PLoS Medicine Announces His Return To An Editorial Development Role At The Lancet

LONDON, October 29 /PRNewswire/ -- Elsevier's premier medical publication, The Lancet welcomes the return of Dr James Butcher to its editorial staff.

"James is a much valued friend and colleague. We are delighted to welcome him back to The Lancet. His decision reaffirms our strategy to continue to be the world's leading general medical journal. James will be a vital part of our collective efforts to extend the global reach and influence of The Lancet," said Dr Richard Horton, Editor of The Lancet.

James previously held the position of Editor at The Lancet Neurology before departing earlier this year to work as Senior Editor at the Public Library of Science's open access medical journal, PLoS Medicine, launched last week.

About The Lancet

Founded in 1823 by surgeon Thomas Wakley with a vision 'to inform, to reform, and to entertain', nearly 200 years later The Lancet's vision remains unchanged. The journal is one of a select few weekly medical titles published worldwide which seeks to influence clinical practice by the publication of high-quality peer-reviewed research covering a broad spectrum of medical disciplines of appeal to clinical practitioners and research academics alike.

In addition to the publication of peer-reviewed research, the journal educates readers through a weekly seminar on a specific topic and regular review articles analysing the status of research in a particular field; regular obituaries and reviews of books, websites, and exhibitions and a lively correspondence section add to The Lancet's vibrancy and colour. Available by print or online subscription, recent developments have seen the emergence of three monthly specialty review journals: The Lancet Oncology, The Lancet Infectious Diseases, and The Lancet Neurology. October 2003 heralded the arrival of 180 years of electronic Lancet archive material from ScienceDirect(R).

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services, which includes The Lancet. Working in partnership with the global science and health communities, Elsevier's 6,800 employees in 86 offices worldwide publish more than 1,800 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

CONTACT: Contact: The Lancet Press Office, Richard Lane, Tel:+44-(0)20-7424-4949, e-mail: pressoffice@lancet.com

Back to news